Do you face troubles in order to be up to
date with all the required legislation changes in various countries in the
Regulatory Pharma & Life Sciences field AND combine it with your supply
chain and tax strategy?
I am happy to inform you that we have recently
launched our Pharma & Life Sciences Regulatory Radar, to strive to assist
you in that regard.
I am pleased to invite you to our Webinar on Precision Medicine and Accurate Indirect Tax
During this digital presentation our panel of experts will give you an overview of possible indirect tax implications within the pharma sector. This panel consists of many tax specialists of the pharmaceutical sector and PwC’s international indirect tax experts. Experts, who are dedicated to the pharmaceutical industry.
I will use my time slot to discuss the implications for Switzerland including which countries will be covered.
You will have the opportunity to exchange your experiences and views on the issue with other international leaders.
Are you a pharmaceutical company selling drugs outlined in the list of special drugs and therapies (“Spezialitätenliste”) in Switzerland? If yes, you could benefit from the following information in connection with Swiss VAT.